(E)-3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)acrylonitrile, 95.0%, 1g

Linsitinib, 250mg

(R)-3-Amino-3-(3,4-dichlorophenyl)propanoic acid hydrochloride, 97.0%, 100mg

(9H-Fluoren-9-yl)methyl (2-(2-(2-aminoethoxy)ethoxy)ethyl)carbamate hydrochloride, 95%, 1g

1-(3-Bromobenzyl)piperidine, 97.0%, 250mg

3-Ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one, 97.0%, 5g

1-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 1g

2-(Trifluoromethyl)cinnamic acid, 95.0%, 5g

(S)-1-(4-Chlorophenyl)propan-1-amine hydrochloride, 95%, 1g

4-Amino-1-ethyl piperidine, 98.0%, 500mg

4,7-dibromo-6-fluoro-2,3-dihydro-1H-indol-2-one, 95.0%, 500mg

N-Hexanoyl-DL-homoserine lactone, 5mg

6-Bromo-1-methyl-1H-pyrrolo[3,2-b]pyridine, 95.0%, 100mg